Clinical Trials Directory

Trials / Sponsors / Aevi Genomic Medicine, LLC, a Cerecor company

Aevi Genomic Medicine, LLC, a Cerecor company

Industry · 12 registered clinical trials.

StatusTrialPhaseStarted
CompletedClinical Trial to Evaluate CERC-002 in Adults With COVID-19 Pneumonia and Acute Lung Injury
COVID-19 Pneumonia, Acute Lung Injury, ARDS
Phase 22020-07-17
CompletedPART B: Efficacy and Safety of AEVI-001 in Children and Adolescents With ADHD and Without mGluR Mutations
Attention Deficit Hyperactivity Disorder
Phase 22018-08-17
CompletedPART A: Efficacy and Safety of AEVI-001 in Children and Adolescents With ADHD and With mGluR Mutations
Attention Deficit Hyperactivity Disorder
Phase 22017-08-28
CompletedA Non-interventional Study to Identify Children and Adolescents With ADHD and With or Without mGLuR Mutations
Attention Deficit Hyperactivity Disorder
—2017-08-14
CompletedPharmacokinetic and Tolerability Study of NFC-1 in Subjects Aged 6-17 Years With ADHD
Attention Deficit Disorder With Hyperactivity
Phase 12017-01-07
CompletedSafety and Efficacy Study of NFC-1 in Subjects Aged 12-17 Years With 22q11.2DS & Associated Neuropsychiatric C
22q11.2 Deletion Syndrome
Phase 12016-11-28
CompletedEfficacy and Safety of NFC-1 in Adolescents With Genetic Disorders Impacting mGluR and ADHD
Attention Deficit Disorder With Hyperactivity
Phase 2 / Phase 32016-06-01
CompletedA Noninterventional Genotype/Phenotype Study of mGluR Mutations in Children and Adolescents With ADHD
Attention Deficit Disorder With Hyperactivity
—2016-02-01
TerminatedTARGTEPO Treatment for Anemia in PD US Trial
Anemia of End Stage Renal Disease
Phase 22015-06-01
TerminatedTARGTEPO Treatment for Anemia in End Stage Renal Disease (ESRD) Patients Undergoing Peritoneal Dialysis (PD)
Anemia of End Stage Renal Disease
Phase 22015-04-01
CompletedPhase I Single Dose, Open-Label Pharmacokinetic Study and Single-Blind, Placebo-Controlled Dose Escalation Stu
Attention-deficit Hyperactivity Disorder (ADHD)
Phase 12015-01-01
CompletedTARGTEPO Treatment for Anemia in Chronic Kidney Disease (CKD) Patients and End-Stage Renal Disease (ESRD)
Chronic Kidney Disease, End Stage Renal Disease
Phase 1 / Phase 22014-05-27